Teller on SDI, Competitiveness

One of the most eminent and controversial scientists of this century, nuclear physicist Edward Teller is perhaps best known for his role in the development of nuclear weapons at Los Alamos National Laboratory during World War II. Often called the “father of the hydrogen bomb,” he also played a controversial role in the loss of security clearance by J. Robert Oppenheimer, the former director of Los Alamos. More recently Teller has been an outspohen advocate of defensive weap- ons, in

Written byPeter Gwynne
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

One of the most eminent and controversial scientists of this century, nuclear physicist Edward Teller is perhaps best known for his role in the development of nuclear weapons at Los Alamos National Laboratory during World War II. Often called the “father of the hydrogen bomb,” he also played a controversial role in the loss of security clearance by J. Robert Oppenheimer, the former director of Los Alamos. More recently Teller has been an outspohen advocate of defensive weap- ons, including the proposed Strategic Defense Initiative.

Born in Budapest in 1908, Teller was educated in Hungary and Germany, receiving a Ph.D. from the University of Leipzig in 1930. He came to the United States in 1935 and was naturalized as a citizen in 1941. He has served on the faculties at George Washington University, the University of Chicago and the University of California and received honorary degrees from more than a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies